Melanoma is one of the few cancers for which mortality has stabilized or even increased. The reason for this is its ability, in later stages, to spread to other parts of the body. New study uncovers the critical factors in the tumor lymphatic microenvironment that promote the melanoma cell distant organ metastasis.
Melanoma is considered metastatic - also called Stage IV melanoma - when the cancer cells have spread through the lymph nodes to distant sites in the body, the most often affected being liver, lungs, bones and brain.
Often primary melanomas grow and spread horizontally on the top layer of the skin before penetrating deeper into the layers of the dermis where they can reach the lymph and blood vessels. Lymphatic invasion and lymph node metastasis correlate with poor clinical outcome in melanoma.
"Because the mechanisms and functional contribution of lymphatic dissemination in distant organ melanoma metastasis remain incompletely understood, we have investigated the contribution of the cells that form the walls of the lymphatic vessels, the lymphatic endothelial cells, to human melanoma cell invasion and metastasis", tells Professor Päivi Ojala from the University of Helsinki, Finland. She continues:
"In particular, our goal was to uncover the critical factors in the tumor lymphatic microenvironment that promote the melanoma cell distant organ metastasis and thereby to generate new leads and potential targets to more efficient treatments and prognosis for metastatic cancer."
Growing human melanoma cells in co-cultures with human primary lymphatic endothelial cells increased the invasive growth of melanoma cells in cell culture conditions that mimick the tissue environment and facilitated melanoma distant organ metastasis in mice implanted with human melanoma cells. This lymphatic endothelium mediated change in the melanoma was dependent on MMP14, Notch3 and 1-integrin proteins, and MMP14 and Notch3 were necessary for the increased metastasis of human melanoma cells in a zebrafish tumor model.
The study uncovers a unique mechanism whereby the direct contact with lymphatic endothelial cells promotes melanoma metastasis.
"These findings can represent new leads that clinicians can consider as prognostic markers for metastasis and the pharmaceutical industry can pursue for further therapeutics development", Professor Ojala says.